Company: AX
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001299709-25-000184
Chunk: 100

Company: Axos Financial, Inc.
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 8
Chunk 100
---
 of input significant to the fair value measurement:September 30, 2025(Dollars in thousands)Significant OtherObservableInputs(Level 2)SignificantUnobservableInputs(Level 3)TotalASSETS:Trading securities$533 $— $533 Available-for-sale securities:Agency MBS46,606 — 46,606 Non-Agency MBS— 11,192 11,192 Municipal— — — Total—Available-for-sale securities:$46,606 $11,192 $57,798 Loans held for sale$12,202 $— $12,202 Servicing rights$— $26,243 $26,243 Other assets—Derivative instruments1$17,892 $— $17,892 LIABILITIES:Accounts payable and other liabilities—Derivative instruments$64,619 $— $64,619 Accounts payable and other liabilities—Contingent Consideration$— $30,810 $30,810 June 30, 2025(Dollars in thousands)Significant OtherObservableInputs(Level 2)SignificantUnobservableInputs(Level 3)TotalASSETS:Trading securities$649 $— $649 Available-for-sale securities:Agency MBS46,757 — 46,757 Non-Agency MBS— 15,569 15,569 Municipal3,682 — 3,682 Total—Available-for-sale securities:$50,439 $15,569 $66,008 Loans held for sale$10,012 $— $10,012 Servicing rights$— $27,218 $27,218 Other assets—Derivative instruments1$17,734 $— $17,734 LIABILITIES:Accounts payable and other liabilities—Derivative instruments$68,498 $— $68,498 1 Other assets - Derivative instruments are presented net of $50.8 million and $55.4 million of variation margin on centrally-cleared derivatives as of September 30, 2025 and June 30, 2025, respectively.The following section describes the valuation methodologies used by the Company to measure various financial instruments at fair value, including an indication of the level in the fair value hierarchy in which each instrument is generally classified. For additional information on the